Roy M. POLLOCK,Scott R. DAIGLE,Eric HEDRICK,Nigel WATERS,Blythe THOMSON
申请号：
US16415325
公开号：
US20200009176A1
申请日:
2019.05.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to DOT1L inhibitors. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof
